| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.01B | 82.88B | 76.89B | 77.96B | 66.85B | 59.98B |
| Gross Profit | 15.73B | 15.71B | 11.98B | 14.89B | 13.21B | 12.90B |
| EBITDA | 8.32B | 7.54B | 7.56B | 8.38B | 9.81B | 8.17B |
| Net Income | 821.00M | 2.23B | 1.51B | 3.15B | 4.66B | 3.82B |
Balance Sheet | ||||||
| Total Assets | 77.57B | 76.28B | 76.41B | 70.66B | 66.87B | 56.87B |
| Cash, Cash Equivalents and Short-Term Investments | 17.23B | 17.12B | 18.70B | 17.69B | 13.82B | 15.46B |
| Total Debt | 10.22B | 10.51B | 13.59B | 11.18B | 7.77B | 9.15B |
| Total Liabilities | 26.15B | 24.25B | 26.03B | 23.43B | 22.54B | 20.67B |
| Stockholders Equity | 51.33B | 51.94B | 50.30B | 47.16B | 44.27B | 36.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.76B | 41.00M | 2.08B | -1.59B | 771.00M |
| Operating Cash Flow | 0.00 | 7.24B | 4.82B | 7.31B | 3.68B | 5.14B |
| Investing Cash Flow | 0.00 | -4.08B | -5.13B | -5.86B | -5.97B | -4.62B |
| Financing Cash Flow | 0.00 | -4.62B | -260.00M | 1.53B | 171.00M | 1.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥61.63B | 13.52 | ― | 1.12% | 14.84% | 7.57% | |
77 Outperform | ¥31.14B | 12.54 | ― | 4.78% | -7.10% | 6.38% | |
74 Outperform | ¥77.62B | 38.22 | ― | 2.20% | 4.75% | 164.54% | |
70 Outperform | ¥41.14B | 11.44 | ― | 4.53% | -2.57% | 3.43% | |
65 Neutral | ¥67.52B | 25.01 | 2.45% | 2.19% | 5.79% | 193.94% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |